Aurinia Pharmaceuticals Inc (AUPH)
5.03
-0.06
(-1.18%)
USD |
NASDAQ |
Apr 24, 16:00
5.03
0.00 (0.00%)
After-Hours: 20:00
Aurinia Pharmaceuticals Cash from Operations (TTM): -33.46M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -33.46M |
| September 30, 2023 | -37.32M |
| June 30, 2023 | -39.41M |
| March 31, 2023 | -64.45M |
| December 31, 2022 | -79.53M |
| September 30, 2022 | -115.90M |
| June 30, 2022 | -140.79M |
| March 31, 2022 | -150.90M |
| December 31, 2021 | -157.69M |
| September 30, 2021 | -128.57M |
| June 30, 2021 | -116.73M |
| March 31, 2021 | -100.79M |
| December 31, 2020 | -69.86M |
| September 30, 2020 | -98.47M |
| June 30, 2020 | -81.83M |
| March 31, 2020 | -73.04M |
| December 31, 2019 | -63.58M |
| September 30, 2019 | -51.79M |
| June 30, 2019 | -51.34M |
| March 31, 2019 | -50.38M |
| December 31, 2018 | -51.61M |
| September 30, 2018 | -46.93M |
| June 30, 2018 | -44.12M |
| March 31, 2018 | -45.83M |
| December 31, 2017 | -41.17M |
| Date | Value |
|---|---|
| September 30, 2017 | -36.50M |
| June 30, 2017 | -32.16M |
| March 31, 2017 | -23.21M |
| December 31, 2016 | -18.71M |
| September 30, 2016 | -19.29M |
| June 30, 2016 | -20.31M |
| March 31, 2016 | -18.96M |
| December 31, 2015 | -17.77M |
| September 30, 2015 | -16.28M |
| June 30, 2015 | -15.09M |
| March 31, 2015 | -15.58M |
| December 31, 2014 | -16.91M |
| September 30, 2014 | -16.11M |
| June 30, 2014 | -13.57M |
| March 31, 2014 | -9.773M |
| December 31, 2013 | -4.62M |
| September 30, 2013 | -2.846M |
| June 30, 2013 | -2.604M |
| March 31, 2013 | -4.937M |
| December 31, 2012 | -6.547M |
| September 30, 2012 | -7.010M |
| June 30, 2012 | -6.980M |
| March 31, 2012 | -5.758M |
| December 31, 2011 | -1.356M |
| September 30, 2011 | -0.8736M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-157.69M
Minimum
Dec 2021
-33.46M
Maximum
Dec 2023
-87.13M
Average
-79.53M
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| Lexaria Bioscience Corp | -5.209M |
| Acasti Pharma Inc | -13.57M |
| Edesa Biotech Inc | -6.252M |
| Xenon Pharmaceuticals Inc | -145.33M |
| ESSA Pharma Inc | -22.19M |